[在AML化疗期间在不同时间点检测流细胞计MRD对预后的影响]
Rui-Xue Ju1, Feng-Qiang Sun1, Yu-Hui Wang2
1Department of Clinical Laboratory Examination, Weifang People's Hospital, Weifang 261041, Shandong Province, China.
Zhongguo shi yan xue ye xue za zhi
|August 27, 2024
概括
在急性髓性白血病 (AML) 化疗期间使用流细胞计检测最小残留疾病 (MRD) 显著影响预后. 实现MRD消极性,特别是在巩固治疗期间,表明AML患者的治疗结果更好.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 流动细胞计量 (Flow Cytometry) 是一种流动细胞计.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
40
